SCIENCE & TECHNOLOGY
With an Eye on Innovation™
We deliver innovative therapeutics to protect vision, specializing in sustained-release treatments for serious retinal diseases.
Durasert E™
- Bioerodible version of the proven, safe Durasert® technology
- Delivered via standard in-office IVT injection
- No delay – reaches target tissue at therapeutic levels within hours
- No free-floating drug – drug is delivered for at least six months before the remaining matrix fully bio-erodes
EyePoint history of Durasert E™ technology – proven safety in thousands of eyes across 4 FDA- approved products, Vitrasert® (B&L), Retisert® (B&L), ILUVIEN® (ANI Pharmaceuticals) and YUTIQ® (ANI Pharmaceuticals)
our programs
Innovation is our vision
Our retinal disease-focused pipeline is built to redefine outcomes for patients.